Elisa Tassinari
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 9
- Prostate Cancer Treatment and Research 6
- Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Matteo Rosellini (26 shared papers)Francesco Massari (27 shared papers)Veronica Mollica (27 shared papers)Andrea Marchetti (26 shared papers)Alessandro Rizzo (12 shared papers)Matteo Santoni (11 shared papers)Valentina Tateo (6 shared papers)Raffaella Massafra (1 shared paper)
- Journals
- Cancers (3 papers)Clinical Genitourinary Cancer (2 papers)Cancer Immunology Immunotherapy (2 papers)RSC Medicinal Chemistry (2 papers)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- ItalySpainUnited States
In The Last Decade
Elisa Tassinari
34 papers receiving 537 citations
Elisa Tassinari's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 161
- Pulmonary and Respiratory Medicine 164
- Hepatology 31
- Cancer Research 51
- Immunology 42
Countries citing papers authored by Elisa Tassinari
This map shows the geographic impact of Elisa Tassinari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Tassinari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Tassinari more than expected).
Fields of papers citing papers by Elisa Tassinari
This network shows the impact of papers produced by Elisa Tassinari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Tassinari. The network helps show where Elisa Tassinari may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisa Tassinari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study Hit paper breakdown → | 2023 | 130 |
| 2 | 2023 | 122 | |
| 3 | 2023 | 120 | |
| 4 | 2021 | 23 | |
| 5 | 2022 | 17 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 10 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2022 | 3 |
About Elisa Tassinari
Elisa Tassinari is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pharmacology and Molecular Biology, having authored 38 papers that have together received 540 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Treatment and Research (6 papers), Urinary and Genital Oncology Studies (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Oncology (161 citations), Pulmonary and Respiratory Medicine (164 citations), Hepatology (31 citations), Cancer Research (51 citations) and Immunology (42 citations). Elisa Tassinari has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Matteo Rosellini, Francesco Massari, Veronica Mollica, Andrea Marchetti, Alessandro Rizzo, Matteo Santoni, Valentina Tateo, Raffaella Massafra, Raffaele De Luca and Fernando Sabino Marques Monteiro. Their work appears in journals such as Cancers, Clinical Genitourinary Cancer, Cancer Immunology Immunotherapy, RSC Medicinal Chemistry and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.